Clinical Trial Update: High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose therapy and peripheral blood stem cell transplantation for HIV-related non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-related Non-hodgkin Lymphoma

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: HIV-related Lymphoma, HIV Infections | Phase 2 | Status: COMPLETED